×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Goldberg Mark Alan

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
IMGNImmunoGen, Inc.Goldberg Mark AlanDirectorDec 29, 2023Option Exercise$29.6556916,87160,720Jan 03, 2024, 05:45 PM
GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorDec 29, 2023Option Exercise$2.365,82713,75220,244Jan 02, 2024, 04:05 PM
IMGNImmunoGen, Inc.Goldberg Mark AlanDirectorOct 30, 2023Option Exercise$14.8920,000297,80070,151Nov 01, 2023, 05:59 PM
GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorSep 30, 2023Option Exercise$1.509,16713,75114,417Oct 03, 2023, 04:15 PM
IMGNImmunoGen, Inc.Goldberg Mark AlanDirectorSep 29, 2023Option Exercise$15.871,06316,87060,151Oct 02, 2023, 05:05 PM
IMGNImmunoGen, Inc.Goldberg Mark AlanDirectorJun 30, 2023Option Exercise$18.8789416,87059,088Jul 05, 2023, 05:53 PM
IMGNImmunoGen, Inc.Goldberg Mark AlanDirectorMar 31, 2023Option Exercise$3.844,39416,87358,194Apr 04, 2023, 04:51 PM
BPMCBlueprint Medicines CorpGoldberg Mark AlanDirectorMar 03, 2022Buy$59.985,000299,90010,812Mar 07, 2022, 04:05 PM
IDRAIDERA PHARMACEUTICALS, INC.Goldberg Mark AlanDirectorJan 04, 2021Option Exercise$4.023,45213,87738,099Jan 06, 2021, 12:00 AM
BPMCBlueprint Medicines CorpGoldberg Mark AlanDirectorDec 24, 2020Option Exercise$76.5710,910835,4339,017Dec 28, 2020, 04:23 PM
BPMCBlueprint Medicines CorpGoldberg Mark AlanDirectorDec 18, 2020Option Exercise$74.0710,908808,0109,016Dec 22, 2020, 04:14 PM
BPMCBlueprint Medicines CorpGoldberg Mark AlanDirectorDec 11, 2020Option Exercise$71.5710,910780,8839,017Dec 15, 2020, 04:08 PM
BPMCBlueprint Medicines CorpGoldberg Mark AlanDirectorDec 01, 2020Option Exercise$69.0710,908753,4709,016Dec 03, 2020, 04:10 PM
BPMCBlueprint Medicines CorpGoldberg Mark AlanDirectorOct 19, 2020Option Exercise$62.2710,910679,3119,017Oct 21, 2020, 04:21 PM
BPMCBlueprint Medicines CorpGoldberg Mark AlanDirectorOct 07, 2020Option Exercise$59.7710,908651,9179,016Oct 09, 2020, 04:04 PM
IDRAIDERA PHARMACEUTICALS, INC.Goldberg Mark AlanDirectorOct 01, 2020Option Exercise$2.256,16613,87434,647Oct 05, 2020, 04:06 PM
IDRAIDERA PHARMACEUTICALS, INC.Goldberg Mark AlanDirectorJul 01, 2020Option Exercise$1.797,75113,87428,481Jul 02, 2020, 08:58 PM
IDRAIDERA PHARMACEUTICALS, INC.Goldberg Mark AlanDirectorApr 01, 2020Option Exercise$1.2810,73013,73420,730Apr 03, 2020, 05:19 PM
BOLDAudentes Therapeutics, Inc.Goldberg Mark AlanDirectorJan 15, 2020Option Exercise$60.001,50090,0000Jan 15, 2020, 01:27 PM
IDRAIDERA PHARMACEUTICALS, INC.Goldberg Mark AlanDirectorDec 19, 2018Buy$3.1910,00031,89710,000Dec 20, 2018, 05:26 PM
IMGNIMMUNOGEN INCGoldberg Mark AlanDirectorNov 06, 2018Buy$5.7630,000172,80053,800Nov 07, 2018, 09:54 AM
IMGNIMMUNOGEN INCGoldberg Mark AlanDirectorDec 15, 2016Buy$1.8020,00036,00023,800Dec 15, 2016, 11:51 AM
GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorMar 04, 2016Buy$4.7710,39749,63011,497Mar 07, 2016, 08:03 AM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanEVP, Medical & Reg. StrategySep 19, 2014Option Exercise$36.981,58058,4361,352Sep 19, 2014, 05:56 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanEVP, Medical & Reg. StrategySep 17, 2014Option Exercise$36.898,400309,9184,762Sep 18, 2014, 05:21 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanEVP, Medical & Reg. StrategySep 16, 2014Option Exercise$36.8718,758691,6079,941Sep 18, 2014, 05:21 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanEVP, Medical & Reg. StrategyJun 30, 2014Option Exercise$54.891035,654562Jul 02, 2014, 05:56 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanEVP, Medical & Reg. StrategyJun 11, 2014Option Exercise$43.8343,1941,893,27322,056Jun 12, 2014, 05:07 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanEVP, Medical & Reg. StrategyDec 31, 2013Option Exercise$36.301926,970459Jan 02, 2014, 07:07 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP,Medical&Regulatory AffairsDec 03, 2013Sale$60.527,000423,649680Dec 04, 2013, 05:07 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP,Medical&Regulatory AffairsDec 02, 2013Option Exercise$8.737,00061,1107,267Dec 04, 2013, 05:07 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP,Medical&Regulatory AffairsNov 01, 2013Sale$29.3514,000410,8637,267Nov 04, 2013, 05:35 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP,Medical&Regulatory AffairsOct 01, 2013Sale$36.5214,000511,3137,267Oct 03, 2013, 04:07 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP,Medical&Regulatory AffairsJun 28, 2013Option Exercise$35.682679,527267Jul 01, 2013, 05:07 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP,Medical&Regulatory AffairsApr 01, 2013Sale$27.638,832244,0264,416Apr 03, 2013, 10:21 AM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP, Product DevelopmentMar 01, 2013Sale$25.868,834228,4134,417Mar 06, 2013, 06:00 AM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP, Product DevelopmentFeb 01, 2013Sale$24.358,834215,0884,417Feb 05, 2013, 05:35 PM
GEVASYNAGEVA BIOPHARMA CORPGoldberg Mark AlanSVP, Product DevelopmentJan 02, 2013Option Exercise$24.248,834214,0924,417Jan 04, 2013, 04:30 PM
IMGNIMMUNOGEN INCGoldberg Mark AlanDirectorNov 08, 2012Buy$11.273,00033,8043,800Nov 09, 2012, 11:06 AM